# Cytobyte, Inc. — Form D

Cytobyte, Inc. of Cleveland, OH, a company, filed a Form D exempt-offering notice with the SEC on 2016-06-02. The offering totals $1.8M. Industry: Biotechnology.

## Offering

- Filed: 2016-06-02
- Form: D
- Accession: 0001676120-16-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.8M
- Remaining: $1.8M
- Minimum investment: $42K
- Date of first sale: 2016-05-23
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-264288

## Issuer

- Name: Cytobyte, Inc.
- CIK: 0001676120
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 1111 Superior Ave., Cleveland, OH, 44114
- Phone: 216-409-2007

## Officers, directors & promoters (1)

| Name | Role | Location |
| --- | --- | --- |
| Jacob Glenn | Executive Officer | Cleveland, OH |

## More

- [CIK 1676120 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1676120&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001676120-16-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.